ifosfamide has been researched along with mitomycin in 143 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (5.59) | 18.7374 |
| 1990's | 54 (37.76) | 18.2507 |
| 2000's | 54 (37.76) | 29.6817 |
| 2010's | 23 (16.08) | 24.3611 |
| 2020's | 4 (2.80) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Benfenati, E; Raska, I; Toropov, AA; Toropova, AP | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Sculier, JP | 1 |
| Artal, A; Chacon, JI; Feliu, J; Garcia de Paredes, ML; Garcia Giron, C; Garrido, P; Gonzalez Baron, M; Ordoñez, A; Zamora, P | 1 |
| Thongprasert, S | 1 |
| Antonakopoulos, GN; Darnton, SJ; Matthews, HR; Newman, J | 1 |
| Chauffert, B; Dimanche-Boitrel, MT; Genne, P; Jeannin, JF; Onier, N; Petit, JM | 1 |
| Gatzemeier, U; Heckmayr, M; Hossfeld, DK; Kaukel, E; Koschel, G; Neuhauss, R | 2 |
| Alonso Muñoz, C; Blanco Guerrero, R; Climent Durán, MA; Germà Lluch, JR; López López, JJ; López Pousa, A; Mercedes Ramírez, A | 1 |
| Vogelzang, NJ | 1 |
| Burmester, H; Carroll, KB; Chang, J; Cuthbert, A; Gomm, SA; Hall, P; Thatcher, N | 1 |
| Abad, A; Barnadas, A; Carles, J; Ribelles, N; Rosell, R; Solano, V | 1 |
| Currie, DC; Drake, JS; Earl, HM; Harper, PG; Miles, DW; Rudd, R; Souhami, RL; Spiro, SG; Tobias, JS | 1 |
| Abad-Esteve, A; Barnadas, A; Carles, J; Culubret, M; Fernandez, C; Moreno, I; Ribelles, N; Rosell, R | 1 |
| Ando, K; Funahashi, H; Imai, T; Kato, M; Kato, N; Narita, T; Odaka, K; Oike, E; Ono, M; Sato, Y | 1 |
| Häussinger, K; Jungbluth, H; Krieger, H; Laumen, R; Otto, M; von Pawel, J | 1 |
| Akagi, T; Hara, M; Nanba, K; Obama, T; Ochi, J; Ozaki, Y; Saegusa, M; Tanahashi, T; Tsushima, T; Yoshimoto, J | 1 |
| Chetiyawardana, AD; Cullen, MH; Joshi, R; Woodroffe, CM | 1 |
| Gatzemeier, U; Hossfeld, DK; Radenbach, D; Zschaber, R | 1 |
| Akiyama, S; Ichihashi, H; Takagi, H | 1 |
| Hino, K; Ibaraki, T; Katou, Y; Kiyozuka, Y; Maruyama, M; Nabuchi, K; Ninomiya, Y; Noda, T; Okamura, Y; Oku, M | 1 |
| Akahoshi, Y; Kasai, C; Nishimoto, Y; Takeuchi, S | 1 |
| Bakowski, MT; Crouch, JC | 1 |
| Herrmann, R; Kreusser, W; Ritz, E; Tschöpe, W | 1 |
| Abad, A; Ariza, A; Barnadas, A; Carles, J; Fernandez-Vasalo, G; Pellicer, I; Rosell, R; Sanchez, JJ | 1 |
| Addamo, GF; Ardizzoni, A; Baldini, E; Borghini, U; Bruzzi, P; Conte, PF; De Marinis, F; Lionetto, R; Pennucci, MC; Portalone, L | 1 |
| Barduagni, M; Carlini, P; Carpi, A; Ceci, G; Clerici, M; Cortesi, E; Crinò, L; Di Costanzo, F; Figoli, F; Santini, A | 1 |
| Camps, C; Font, A; Gómez-Codina, J; Li, S; Martínez, E; Molina, F; Moreno, I; Pifarré, A; Rosell, R; Skacel, Z | 1 |
| Cullen, MH | 2 |
| Macbeth, F; Milroy, R | 1 |
| Boni, C; Carlini, P; Carpi, A; Ceci, G; Clerici, M; Cortesi, E; Crinò, L; Di Costanzo, F; Figoli, F; Santini, A | 1 |
| Antonakopoulos, GN; Darnton, SJ; Duffy, JP; Matthews, HR; Newman, J | 1 |
| Allen, SM; Cullen, MH; Darnton, SJ; Duffy, JP; Matthews, HR; Walker, SJ | 1 |
| Elliott, WL; Howard, CT; Leopold, WR; Roberts, BJ | 1 |
| Blanco, E; Colmenarejo, A; de la Gándara, I; Espinosa, E; Feliu, J; García Girón, C; Garrido, P; González Barón, M; Moyano, A; Ordóñez, A | 1 |
| Chastang, C; Depierre, A; Jacoulet, P; Janicot, H; Lebeau, B; Lombard, JN; Milleron, B; Moro, D; Paillot, N; Quoix, E | 1 |
| Camps, C; Font, A; Gómez-Codina, J; Maestre, J; Milla, A; Molina, F; Moreno, I; Rosell, R | 1 |
| Arcangeli, G; Marini, G; Marpicati, P; Meriggi, F; Milano, S; Simoncini, E; Zaniboni, A | 1 |
| Artal, A; Barón, JM; Berrocal, A; Feliu, J; García Girón, C; Garrido, P; González Barón, M; Ordóñez, A | 1 |
| Allen, SM; Darnton, SJ; Edwards, CW; Matthews, HR | 1 |
| Köpf-Maier, P; Sass, G | 1 |
| Darnton, SJ; Ferry, DR; Jenner, K; Matthews, HR; Steyn, RS | 1 |
| Allen, SM; Cullen, MH; Darnton, SJ; Duffy, JP; Matthews, HR | 1 |
| Di Fabio, D; Marini, G; Milano, S; Mombelloni, G; Ottoni, DB; Zaniboni, A; Zorzi, F | 1 |
| Brandt, A; Palmer, AJ | 1 |
| Cachat, F; Guignard, JP | 1 |
| Shimizu, Y | 1 |
| Crinó, L; Mosconi, AM; Tonato, M | 1 |
| Corgna, E; Crinò, L; Darwish, S; Minotti, V; Mosconi, AM; Palladino, MA; Porrozzi, S; Tonato, M | 1 |
| Cooper, K; Sur, M; Sur, RK; Taylor, L | 1 |
| Akusawa, H; Horie, T; Kadota, A; Koya, Y; Masutani, M; Ohchi, Y; Takahashi, N; Tanigawa, S | 1 |
| Buckner, JC; Lewis, JE; McElroy, EA | 1 |
| Antilli, A; Ardizzoni, A; Baldini, E; Bandera, M; Barbera, S; Borghini, U; Cacciani, GC; Crippa, M; De Marinis, F; Ferrara, G; Fioretti, M; Galeasso, G; Lanfranco, C; Lepidini, G; Migliorino, MR; Noseda, MA; Pennucci, MC; Portalone, L; Raimondi, M; Rinaldi, M; Romano, F; Rosso, R; Salvati, F; Sunseri, G; Tibaldi, C | 1 |
| Ip, M; Lam, WK; Tsang, KW | 1 |
| Choi, BG; Han, JY; Hong, YS; Kim, HK; Lee, KS; Moon, H | 1 |
| Hongo, A; Ikuhashi, H; Kobashi, Y; Kodama, J; Kudo, T; Miyagi, Y; Mizutani, Y; Okuda, H; Yoshinouchi, M | 1 |
| Baumöhl, J; Berchier, MC; Bureau, G; Giner, V; Klastersky, J; Lafitte, JJ; Mommen, P; Ninane, V; Paesmans, M; Recloux, P; Sculier, JP; Thiriaux, J; van Cutsem, O; van Houtte, P; Zacharias, C | 1 |
| Günzburg, WH; Karle, P; Renner, M; Renz, R; Salmons, B | 1 |
| Bessell, E; Billingham, LJ; Chetiyawardana, AD; Connolly, CK; Cook, JE; Cullen, MH; Ferry, DR; Gower, NH; Joshi, R; Rudd, RM; Souhami, RL; Spiro, SG; Tobias, J; Trask, C; Woodroffe, CM | 1 |
| Adamo, V; Barni, S; Bianco, R; Ceribelli, A; Crinò, L; Cruciani, G; De Marinis, F; Di Costanzo, F; Ferrara, G; Gozzelino, F; Gridelli, C; Marangolo, M; Masotti, A; Portalone, L; Ravaioli, A; Ricci, S; Rinaldi, M; Sassi, M; Scagliotti, GV; Tonato, M | 1 |
| Abad, A; Camps, C; Cantó, A; Gómez-Codina, J; Javier Sánchez, J; Maestre, J; Padilla, J; Roig, J; Rosell, R | 1 |
| Cheverton, PD; Davidson, NG; Davis, AS; Snooks, S; Woods, J | 1 |
| Ochiai, K | 1 |
| Sandler, A | 1 |
| Alexopoulos, CG; Baumöhl, J; Berghmans, T; Florin, MC; Klastersky, J; Koumakis, G; Lafitte, JJ; Mommen, P; Ninane, V; Paesmans, M; Schmerber, J; Sculier, JP; Thiriaux, J; Zacharias, C | 1 |
| Aktoğu, S; Büyükşirin, M; Capa, G; Durak, H; Erkmen, G; Ertay, T; Ozbilek, E; Sayit, E | 1 |
| Gérinière, L; Souquet, PJ | 1 |
| Arnau Obrer, A; Cantó Armengod, A; Cervera Juan, A; Granell Gil, M; Martín Díaz, E; Pérez Alonso, D; Regueiro Mira, F; Roch Pendería, S | 1 |
| Arnau Obrer, A; Cañizares Carretero, M; Cantó Armengod, A; Cervera Juan, A; Granell Gil, M; Martín Díaz, E; Pérez Alonso, D; Regueiro Mira, F; Roch Tejerina, S | 1 |
| Archer, VR; Darnton, SJ; Ferry, DR; Mulholland, PJ; Stocken, DD | 1 |
| Rixe, O | 1 |
| Baud, M; Collon, T; Febvre, M; Le Guen, Y; Lebeau, B; Touboul, E; Urban, T | 1 |
| Burgut, R; Erkisi, M; Erkurt, E; Kocabas, A; Tunali, C; Zeren, H | 1 |
| Blanchon, F; Braun, D; Bréchot, JM; Breton, JL; Chastang, C; Chevret, S; Clavier, J; Coëtmeur, D; Depierre, A; Foucher, P; Gouva, S; Janicot, H; Lebas, FX; Lebeau, B; Leclerc, P; Lemarié, E; Level, MC; Milleron, B; Monchâtre, M; Moro-Sibilot, D; Paillot, N; Quoix, E; Rodier, JM; Terrioux, P; Thiberville, L; Villeneuve, A; Westeel, V | 1 |
| Rosell, R | 1 |
| Billingham, LJ; Cullen, MH | 1 |
| Buckner, JC; Edmonson, JH; Foo, ML; Gunderson, LL; Haddock, MG; Mahoney, MR; Maples, WJ; O'Connor, MI; Petersen, IA; Pritchard, DJ; Rock, MG; Shives, TC; Sim, FH; Stafford, SL | 1 |
| Chu, DT; Li, JL; Qu, FL; Sun, Y; Zhang, XR | 1 |
| Hosomi, Y; Shibuya, M | 1 |
| Bathers, S; Billingham, LJ; Bryan, S; Burton, A; Cullen, MH | 1 |
| Crinò, L | 1 |
| Du, CW; Li, DR; Lin, W; Lin, Y; Lin, YC; Wu, MY | 1 |
| Bilkei-Gorzo, A; Michel, K; Palkovits, M; Racz, I; Toth, ZE; Zimmer, A | 1 |
| Anderson, H; Ashcroft, L; Beresford, C; Burt, PA; Clemons, M; Danson, S; Dowd, I; Fairve-Finn, C; Hassan, J; Middleton, MR; O'Byrne, KJ; Ranson, M; Stout, R; Thatcher, N | 1 |
| Ernst, H; Fahrig, R; Fiedler, B; Heinrich, JC; Krupitza, G; Leisser, C; Nickel, B; Praha, C; Scherthan, H; Sonntag, D; Wilfert, F | 1 |
| Brasiūnas, V; Brasiūniene, B; Inciūra, A; Juozaityte, E | 1 |
| Archer, VR; Casson, AG; Darnton, SJ; Ferry, DR; Mulholland, PJ; Stocken, DD | 1 |
| Barrow, E; Barrow, WW; Flavin, MT; Lin, YM; Suling, WJ; Westbrook, L; Xu, ZQ | 1 |
| Berghmans, T; Corhay, JL; Efremidis, A; Giner, V; Koumakis, G; Lafitte, JJ; Lecomte, J; Lothaire, P; Mommen, P; Ninane, V; Paesmans, M; Richez, M; Sculier, JP; Thiriaux, J; Van Houtte, P; Wackenier, P | 1 |
| Müller, H; Nakchbandi, V | 1 |
| Berghmans, T; Corhay, JL; Efremidis, A; Giner, V; Koumakis, G; Lafitte, JJ; Lecomte, J; Lothaire, P; Mommen, P; Ninane, V; Richez, M; Sculier, JP; Thiriaux, J; VanHoutte, P; Wackenier, P | 1 |
| Amadori, S; Anak, O; Beeldens, F; De Witte, T; Denzlinger, C; Fabris, P; Hagemeijer, A; Ho, A; Leone, G; Mandelli, F; Muus, P; Selleslag, D; Stauder, R; Suciu, S; Vignetti, M; Willemze, R | 1 |
| Eisen, TG; Gower, NH; Gregory, WM; Harper, PG; Hatton, M; James, LE; Johnson, PW; Lee, SM; Littler, JA; Martin, WM; Qian, W; Rankin, EM; Rudd, RM; Spiro, SG | 1 |
| de Bree, E; Relakis, K; Romanos, J; Tsiftsis, DD | 1 |
| Breton, JL; Debieuvre, D; Depierre, A; Haller, MA; Herman, D; Lebas, FX; Level, MC; Mercier, M; Milleron, B; Moro-Sibilot, D; Puyraveau, M; Quoix, E; Richard, P; Westeel, V | 1 |
| Girling, DJ; Hopwood, P; Stephens, RJ; Thatcher, N | 1 |
| Furuhashi, M; Ishikawa, K; Ishizuka, T; Kidokoro, K; Kuno, N; Miyazaki, K; Mizuno, K; Mizuno, M; Nakagawa, A; Suzuki, S; Yoshida, K | 1 |
| Ishida, T; Kiwada, H; Nguyen, LT | 1 |
| Berghmans, T; Sculier, JP | 1 |
| Braun, D; Depierre, A; Lebeau, B; Milleron, B; Moro-Sibilot, D; Quoix, E; Westeel, V | 1 |
| Govindan, R | 1 |
| Ferry, DR; Tho, LM | 1 |
| Berghmans, T; Meert, AP; Ninane, V; Sculier, JP | 1 |
| Anderson, H; Ashcroft, L; Baka, S; Booton, R; Dark, G; Dunlop, D; Laurence, V; Lorigan, P; Nicolson, M; O'Brien, M; O'Byrne, K; Snee, M; Thatcher, N | 1 |
| Depierre, A | 1 |
| Alexander, JP; Cravatt, BF | 1 |
| Atil, H; Aysan, T; Cok, G; Göksel, T; Güzelant, A; Soyer, S | 1 |
| Bowman, E; Coskun, O; Gendelman, HE; Laurie, C; Mosley, RL; Reynolds, A | 1 |
| Ashcroft, L; Booten, R; Booton, R; Heighway, J; Morris, J; Thatcher, N; Ward, T | 1 |
| Jang, JH; Yotsu-Yamashita, M | 1 |
| Ashcroft, L; Booton, R; Heighway, J; Morris, J; Thatcher, N; Ward, T | 1 |
| Ahn, JS; Ahn, MJ; Hwang, IG; Im, YH; Kang, WK; Lee, SC; Lim, HY; Park, BB; Park, K | 1 |
| Eyster, CA; Olson, AL | 1 |
| Chen, SW; Chiang, LW; Huang, HL; Lin, KJ; Pei, K; Yen, TC; Yu, CS | 1 |
| Deutsch, E; Loriot, Y; Mordant, P; Olaussen, KA; Soria, JC | 1 |
| Bhatt, L; Fernando, I | 1 |
| Andersson, JO; Backhans, A; Christensson, B; Lebbad, M; Ljungström, B; Mattsson, JG; Svärd, SG | 1 |
| Kochanek, S; Larochelle, N; Lochmüller, H; Rieger, N; Schermelleh, L; Schiedner, G; Stucka, R; Wolf, E | 1 |
| Gordon, TP; Haberberger, RV; Jackson, MW; Park, K | 1 |
| Brioschi, M; Ceraulo, D; Cereda, S; Fugazza, C; Ghidini, M; Nicoletti, R; Reni, M; Rognone, A; Villa, E | 1 |
| Helming, L | 1 |
| Berchier, MC; Berghmans, T; Bosschaerts, T; Giner, V; Lafitte, JJ; Leclercq, N; Lewin, D; Meert, AP; Paesmans, M; Scherpereel, A; Sculier, JP | 1 |
| David, P; Depierre, A; Ducoloné, A; Milleron, B; Molinier, O; Monnet, E; Mouillet, G; Puyraveau, M; Quoix, E; Westeel, V; Zalcman, G | 1 |
| Badie, H; Bu, G; Cai, L; Chen, Y; Gage, FH; Hong, W; Johnson, PF; Lipton, SA; Loo, LS; Mobley, WC; Mu, Y; Ranscht, B; Thompson, RC; Wang, X; Wu, C; Xu, H; Yang, B; Zhang, D; Zhang, X; Zhang, YW; Zhao, Y; Zhou, Y | 1 |
| Ozdemir, O; Ozdemir, P; Ozhan, MH; Uluer, H; Veral, A | 1 |
| Bar-Sela, G; Miller, RC; Novotny, PJ; Sio, TT; Sohawon, S; Thariat, J; Van Houtte, P; Vu, CC | 1 |
| Haddock, M; Mahoney, M; Maples, W; Markovic, SN; O'Connor, MI; Okuno, S; Petersen, I; Shives, T; Sim, F | 1 |
| Baxley, A; Khawandanah, M; Pant, S | 1 |
| Bao, H; Chen, H; Cui, P; Deng, G; Kong, H; Lu, K; Mu, G; Shi, J; Tian, G; Wang, X; Xu, X; Zeng, X | 1 |
| Davy, A; Gautrais, J; Khuong, A; Laussu, J | 1 |
| Ali-El-Dein, B; Babjuk, M; Burger, M; Chang, SS; Clayman, RH; Daneshmand, S; Efstathiou, JA; Fritsche, HM; Gakis, G; Galland, S; Hrbacek, J; Keegan, KA; Mischinger, J; Morgan, TM; Olugbade, K; Rink, M; Schubert, T; Stenzl, A; Thalmann, GN; Todenhöfer, T; Zaid, HB | 1 |
| Dheen, ST; Karthikeyan, A; Ling, EA; Lu, J; Rangarajan, P | 1 |
| Inagawa, H; Kohchi, C; Nisizawa, T; Saika, T; Soma, G; Uenobe, M | 1 |
| Ambrosio, L; Dieleman, LA; Dunsmore, G; Elahi, S; Ghobakhloo, N; Hotte, N; Huang, V; Koleva, P; Madsen, KL; Meng, X; Nguyen, V; Sutton, R | 1 |
| Caldwell, RB; Caldwell, RW; Chen, Y; Li, Z; Lian, J; Lv, H; Ni, H; Shi, G; Wu, R; Xia, Y; Xu, Y; Yao, L; Zhu, C | 1 |
| Azizi, M; Bouzari, S; Fasihi-Ramandi, M; Sadeghi, Z | 1 |
| Ham, DW; Kim, SG; Lee, SH; Seo, SH; Shin, EH; Shin, JH | 1 |
| Chen, L; Chen, Q; Hu, J; Wu, Y; Zhu, M; Zhuang, Z | 1 |
| Bao, X; Ding, H; He, JX; Miao, ZH; Song, S; Tan, J; Xiong, C; Zhang, A; Zhang, N; Zhao, J; Zhou, L | 1 |
21 review(s) available for ifosfamide and mitomycin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Non-small-cell lung cancer (NSCLC): chemotherapy in advanced disease. Our experience in ten years.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Humans; Ifosfamide; Lomustine; Lung Neoplasms; Methotrexate; Mitomycin; Mitomycins | 1992 |
Nephrotoxicity from chemotherapy: prevention and management.
Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Gallium; Humans; Ifosfamide; Kidney Diseases; Methotrexate; Mitomycin; Neoplasms; Nitrosourea Compounds; Plicamycin | 1991 |
A randomized study of two vindesine plus cisplatin-containing regimens with the addition of mitomycin C or ifosfamide in patients with advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Protocols; Female; Humans; Ifosfamide; L-Lactate Dehydrogenase; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Random Allocation; Remission Induction; Survival Rate; Vindesine | 1990 |
Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Dianhydrogalactitol; Doxorubicin; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Mitomycins; Random Allocation; Vinblastine; Vindesine | 1983 |
Nephrological complications of cancer therapy.
Topics: Acute Kidney Injury; Antineoplastic Agents; Cisplatin; Cyclophosphamide; Humans; Ifosfamide; Kidney; Kidney Diseases; Methotrexate; Mitomycin; Mitomycins; Nitrosourea Compounds; Vinblastine; Vincristine | 1982 |
Trials with mitomycin, ifosfamide and cisplatin in non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Palliative Care; Survival Rate; Treatment Outcome; United Kingdom | 1995 |
Neoadjuvant chemotherapy in stage IIIa non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin | 1995 |
The cost-effectiveness of four cisplatin-containing chemotherapy regimens in the treatment of stages III B and IV non-small cell lung cancer: an Italian perspective.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cost-Benefit Analysis; Deoxycytidine; Etoposide; Gemcitabine; Health Care Costs; Humans; Ifosfamide; Insurance, Health, Reimbursement; Italy; Lung Neoplasms; Mitomycin; Ribonucleotide Reductases; Vinblastine; Vinorelbine | 1996 |
[The kidney in children under chemotherapy].
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Carboplatin; Child; Cisplatin; Glomerular Filtration Rate; Humans; Ifosfamide; Kidney; Kidney Diseases; Kidney Function Tests; Methotrexate; Mitomycin; Semustine | 1996 |
[Consecutive low-dose cisplatin-based chemotherapy for gynecologic malignancies].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Genital Neoplasms, Female; Humans; Ifosfamide; Mitomycin; Ovarian Neoplasms; Paclitaxel; Uterine Cervical Neoplasms; Uterine Neoplasms; Vincristine | 1997 |
Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Esthesioneuroblastoma, Olfactory; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Lymphatic Metastasis; Male; Mesna; Methotrexate; Middle Aged; Mitomycin; Nasal Cavity; Nose Neoplasms; Paranasal Sinus Neoplasms; Remission Induction; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine | 1998 |
[Gynecologic cancer-evidenced based chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Evidence-Based Medicine; Female; Fluorouracil; Humans; Ifosfamide; Mitomycin; Ovarian Neoplasms; Survival Analysis; Treatment Outcome; Uterine Cervical Neoplasms; Uterine Neoplasms; Vincristine | 2000 |
Chemotherapy in metastatic non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Ifosfamide; Irinotecan; Lung Neoplasms; Mitomycin; Paclitaxel; Taxoids; Tirapazamine; Triazines; Vinblastine; Vinorelbine | 2000 |
[Chemotherapy of stage IV non-small-cell lung cancer: contribution of gemcitabine].
Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Deoxycytidine; Gemcitabine; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Paclitaxel; Prognosis; Randomized Controlled Trials as Topic; Vinblastine; Vinorelbine | 2000 |
The treatment of advanced non-small-cell lung cancer (NSCLC)--overseas updated and local experiences.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials, Phase III as Topic; Epirubicin; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Survival Rate | 2002 |
[ Early anti-cancer drugs].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Vinblastine; Vindesine | 2002 |
[The update on pancreatic cancer chemotherapy].
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Cisplatin; Deoxycytidine; Female; Fluorouracil; Gemcitabine; Humans; Ifosfamide; Infusions, Intra-Arterial; Irinotecan; Male; Mitomycin; Multicenter Studies as Topic; Pancreatic Neoplasms; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Taxoids; Time Factors | 2003 |
Compartmentalization and regulation of insulin signaling to GLUT4 by the cytoskeleton.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytoskeleton; Glucose Transporter Type 4; Humans; Ifosfamide; Insulin; Mitomycin; Signal Transduction | 2009 |
Are RAS mutations predictive markers of resistance to standard chemotherapy?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials, Phase III as Topic; Clinical Trials, Phase IV as Topic; Colorectal Neoplasms; Combined Modality Therapy; Drug Resistance, Neoplasm; Drug Therapy; Etoposide; Genes, ras; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Mutation; Predictive Value of Tests; Prognosis; Survival Analysis; Treatment Outcome | 2009 |
Beyond boundaries--Eph:ephrin signaling in neurogenesis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Adhesion; Cell Movement; Cisplatin; Embryonic Development; Ephrins; Female; Humans; Ifosfamide; Mitomycin; Models, Theoretical; Morphogenesis; Neurogenesis; Pregnancy; Protein Binding; Receptors, Eph Family; Signal Transduction; Stem Cells | 2014 |
55 trial(s) available for ifosfamide and mitomycin
| Article | Year |
|---|---|
A randomized trial with mitomycin-C/ifosfamide versus mitomycin-C/vindesine versus cisplatin/etoposide in advanced non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Prognosis; Survival Rate; Vindesine | 1991 |
High dose combination chemotherapy with ifosfamide, cyclophosphamide or cisplatin, mitomycin C and mustine with autologous bone marrow support in advanced non-small cell lung cancer. A phase I/II study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cyclophosphamide; Drug Evaluation; Humans; Ifosfamide; Lung Neoplasms; Mechlorethamine; Middle Aged; Mitomycin; Mitomycins; Survival Rate; Transplantation, Autologous | 1991 |
A randomized study of two vindesine plus cisplatin-containing regimens with the addition of mitomycin C or ifosfamide in patients with advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Protocols; Female; Humans; Ifosfamide; L-Lactate Dehydrogenase; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Random Allocation; Remission Induction; Survival Rate; Vindesine | 1990 |
[Chemotherapy of advanced non-small cell bronchial cancer with mitomycin C/ifosfamide versus mitomycin C/vindesine versus cisplatin/etoposide--a prospective randomized study].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Mitomycins; Prospective Studies; Randomized Controlled Trials as Topic; Vindesine | 1990 |
Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Dianhydrogalactitol; Doxorubicin; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Mitomycins; Random Allocation; Vinblastine; Vindesine | 1983 |
Mitomycin-ifosfamide-cisplatinum (MIP) vs MIP-interferon vs cisplatinum-carboplatin in metastatic non-small-cell lung cancer: a FONICAP randomised phase II study. Italian Lung Cancer Task Force.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Ifosfamide; Interferons; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins | 1995 |
Superiority of three-drug combination chemotherapy versus cisplatin-etoposide in advanced non-small cell lung cancer: a randomized trial by the Italian Oncology Group for Clinical Research.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mitomycin; Survival Rate; Treatment Outcome; Vindesine | 1995 |
Mutated K-ras gene analysis in a randomized trial of preoperative chemotherapy plus surgery versus surgery in stage IIIA non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; DNA Mutational Analysis; DNA, Neoplasm; Genes, ras; Genotype; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Point Mutation; Remission Induction; Survival Rate; Treatment Outcome | 1995 |
Trials with mitomycin, ifosfamide and cisplatin in non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Palliative Care; Survival Rate; Treatment Outcome; United Kingdom | 1995 |
Neoadjuvant chemotherapy in stage IIIa non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin | 1995 |
Chemotherapy of advanced non-small-cell lung cancer: a comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Italy; Lung Neoplasms; Male; Middle Aged; Mitomycin; Multivariate Analysis; Neoplasm Staging; Retrospective Studies; Survival Rate; Vindesine | 1995 |
A phase II study of mitomycin, ifosfamide and cisplatin in operable and inoperable squamous cell carcinoma of the oesophagus.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Female; Humans; Ifosfamide; Male; Middle Aged; Mitomycin; Mitomycins | 1994 |
Comparison of two chemotherapeutic regimens--mitomycin + vindesine + cisplatin (MVP) vs. mitomycin + ifosfamide + cisplatin (MIP)--in advanced non-small-cell lung cancer. ONCOPAZ Cooperative Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Progesterone; Prospective Studies; Remission Induction; Survival Rate; Vinblastine | 1994 |
An ongoing randomized study of neoadjuvant chemotherapy in resectable non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Middle Aged; Mitomycin; Mitomycins; Survival Analysis | 1994 |
A randomized trial of mitomycin/ifosfamide/cisplatin preoperative chemotherapy plus surgery versus surgery alone in stage IIIA non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Mitomycins; Neoplasm Staging; Survival Analysis | 1994 |
MICE: a new active combination for non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Remission Induction; Vindesine | 1993 |
Mitomycin, ifosfamide, and cisplatin in non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Dexamethasone; Drug Administration Schedule; Furosemide; Humans; Ifosfamide; Lung Neoplasms; Mesna; Metoclopramide; Mitomycin; Mitomycins; Nausea; Neoplasm Staging; Vomiting | 1993 |
Randomized phase II trial comparing two chemotherapy combinations for non-small cell lung cancer. Mitomycin, ifosfamide, and cisplatin versus vindesine, ifosfamide, and cisplatin.
Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Survival Analysis; Vindesine | 1993 |
Phase II study of mitomycin, ifosfamide and cisplatin in adenocarcinoma of the oesophagus.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Esophageal Neoplasms; Humans; Ifosfamide; Male; Middle Aged; Mitomycin; Mitomycins; Treatment Outcome | 1996 |
Rationale of a phase III study comparing a standard cisplatin regimen (mitomycin/ifosfamide/cisplatin) with cisplatin and gemcitabine in non-small cell lung cancer.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Ribonucleotide Reductases | 1997 |
A better therapeutic profile for the combination of mitomycin-C, ifosfamide and cisplatin (MIC) in advanced non-small-cell lung cancer: a useful dose-schedule modification.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin | 1997 |
A phase III randomized trial of cisplatin plus vindesine versus cisplatin plus vindesine plus mitomycin C versus cisplatin plus vindesine plus ifosfamide for advanced non-small-cell lung cancer.
Topics: Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Survival Analysis; Treatment Outcome; Vinblastine; Vindesine | 1996 |
Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): a FONICAP randomized phase II study. Italian Lung Cancer Task Force (FONICAP).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Vinblastine; Vindesine | 1998 |
Quality of life (QOL) assessment of MIP (mitomycin, ifosfamide and cisplatin) chemotherapy in advanced non-small cell lung cancers (NSCLC).
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Nausea; Quality of Life; Survival Analysis; Treatment Outcome; Vomiting | 1998 |
Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Prognosis; Quality of Life; Survival Analysis | 1999 |
Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Dose-Response Relationship, Drug; Female; Gemcitabine; Humans; Ifosfamide; Italy; Lung Neoplasms; Male; Middle Aged; Mitomycin; Quality of Life; Sample Size; Survival Rate | 1999 |
Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Evaluation Studies as Topic; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Middle Aged; Mitomycin; Preoperative Care | 1999 |
FILM (5-fluorouracil, ifosfamide, leucovorin and mitomycin C), an alternative chemotherapy regimen suitable for the treatment of advanced breast cancer in the 'out-patient' setting.
Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Breast Neoplasms, Male; Female; Fluorouracil; Humans; Ifosfamide; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Outpatient Clinics, Hospital; Survival Rate; Treatment Outcome | 1999 |
Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dose-Response Relationship, Drug; Female; Humans; Ifosfamide; Leukopenia; Lung Neoplasms; Male; Middle Aged; Mitomycin; Multivariate Analysis; Neoplasm Staging; Survival Analysis; Survival Rate; Thrombocytopenia; Time Factors; Treatment Outcome | 2000 |
Effect of chemotherapy on pulmonary epithelial permeability in lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Gas Analysis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cell Membrane Permeability; Cisplatin; Doxorubicin; Etoposide; Forced Expiratory Volume; Humans; Ifosfamide; Lung; Lung Neoplasms; Male; Metabolic Clearance Rate; Middle Aged; Mitomycin; Mucociliary Clearance; Respiratory Mucosa; Technetium Tc 99m Pentetate; Vital Capacity | 2000 |
Combined results from three phase II trials of neoadjuvant chemotherapy in operable adenocarcinoma of the oesophagus.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Esophageal Neoplasms; Female; Fluorouracil; Follow-Up Studies; Humans; Ifosfamide; Male; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Survival Analysis; Treatment Outcome | 2001 |
Anticipated administration of GM-CSF in the treatment of non small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Middle Aged; Mitomycin; Recombinant Proteins; Survival Rate | 2001 |
Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Preoperative Care; Proportional Hazards Models; Survival Rate | 2002 |
The benefits of chemotherapy in patient subgroups with unresectable non-small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mitomycin; Neoplasm Staging; Palliative Care; Prognosis; Quality of Life; Survival Rate; Treatment Outcome | 2001 |
Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factor.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Infusions, Intravenous; Injections, Subcutaneous; Leukopenia; Male; Mesna; Middle Aged; Mitomycin; Neoadjuvant Therapy; Sarcoma; Soft Tissue Neoplasms; Thrombocytopenia; Treatment Outcome; Vomiting | 2002 |
Patterns, costs and cost-effectiveness of care in a trial of chemotherapy for advanced non-small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Costs and Cost Analysis; Female; Home Care Services, Hospital-Based; Hospital Costs; Hospitalization; Humans; Ifosfamide; Length of Stay; Lung Neoplasms; Male; Middle Aged; Mitomycin; Palliative Care; Prospective Studies; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome | 2002 |
[Comparison of effects of three chemotherapy regimens for advanced non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Paclitaxel; Taxoids; Treatment Outcome | 2002 |
Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Carboplatin; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Disease Progression; Dose-Response Relationship, Drug; Female; Gemcitabine; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Staging; Quality of Life; Survival Rate; Time Factors; Vinblastine | 2003 |
Preoperative mitomycin, ifosfamide, and cisplatin followed by esophagectomy in squamous cell carcinoma of the esophagus: pathologic complete response induced by chemotherapy leads to long-term survival.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Cohort Studies; Combined Modality Therapy; Drug Administration Schedule; Esophageal Neoplasms; Esophagectomy; Female; Humans; Ifosfamide; Male; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Northern Ireland; Radiography; Survival Analysis; Treatment Outcome | 2003 |
A phase III randomised study comparing two different dose-intensity regimens as induction chemotherapy followed by thoracic irradiation in patients with advanced locoregional non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Remission Induction; Survival Rate; Thorax; Treatment Outcome | 2004 |
Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a phase II study (AML-15) of the EORTC and GIMEMA leukemia groups.
Topics: Acute Disease; Aged; Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Female; Gemtuzumab; Humans; Ifosfamide; Infusions, Intravenous; Leukemia, Myeloid; Male; Middle Aged; Mitomycin; Reproducibility of Results; Survival Analysis; Vindesine | 2004 |
Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Quality of Life; Survival Rate; Treatment Outcome | 2005 |
Randomized study of maintenance vinorelbine in responders with advanced non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease-Free Survival; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Odds Ratio; Proportional Hazards Models; Remission Induction; Survival Analysis; Treatment Failure; Treatment Outcome; Vinblastine; Vinorelbine | 2005 |
A randomised controlled trial of pre-operative chemotherapy followed, if feasible, by resection versus radiotherapy in patients with inoperable stage T3, N1, M0 or T1-3, N2, M0 non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Quality of Life; Radiotherapy; Time Factors; Treatment Outcome; Vindesine | 2005 |
[Neoadjuvant chemotherapy with intra-arterial infusion in the treatment of advanced cervical cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Female; Humans; Hysterectomy; Ifosfamide; Infusions, Intra-Arterial; Lymph Node Excision; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Staging; Prognosis; Survival Rate; Uterine Cervical Neoplasms; Vincristine | 2005 |
Chemotherapy for metastatic NSCLC: current status and future direction.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Quality of Life; Survival Analysis; Treatment Outcome | 2005 |
Mitomycin, ifosfamide, cisplatin for non-small cell lung cancer: an implementation study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bronchoscopy; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Remission Induction; Retrospective Studies; Treatment Outcome | 2005 |
A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology Group
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Quality of Life; Survival Analysis; Taxoids; Vinblastine | 2006 |
Glutathione-S-transferase P1 isoenzyme polymorphisms, platinum-based chemotherapy, and non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Genotype; Glutathione S-Transferase pi; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Polymorphism, Genetic; Survival Rate; Vinblastine | 2006 |
ERCC1 mRNA expression is not associated with response and survival after platinum-based chemotherapy regimens in advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; DNA Repair; DNA-Binding Proteins; Docetaxel; Endonucleases; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mitomycin; Neoplasm Staging; Neoplasms, Squamous Cell; Polymorphism, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Rate; Taxoids; Treatment Outcome | 2007 |
Salvage chemotherapy with mitomycin C, ifosfamide, and cisplatin (MIC) for previously treated metastatic or recurrent esophageal squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Esophageal Neoplasms; Humans; Ifosfamide; Male; Middle Aged; Mitomycin; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neutropenia; Salvage Therapy; Survival Rate; Treatment Outcome | 2008 |
Salvage therapy with mitomycin and ifosfamide in patients with gemcitabine-resistant metastatic pancreatic cancer: a phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Ifosfamide; Male; Middle Aged; Mitomycin; Pancreatic Neoplasms; Salvage Therapy | 2011 |
Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): a phase II randomised study by the European Lung Cancer Working
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Costs and Cost Analysis; Deoxycytidine; Female; Gemcitabine; Humans; Ifosfamide; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Mitomycin; Multivariate Analysis; Neoadjuvant Therapy; Proportional Hazards Models; Treatment Outcome; Vinblastine; Vinorelbine | 2012 |
Pathologic complete response to preoperative chemotherapy predicts cure in early-stage non-small-cell lung cancer: combined analysis of two IFCT randomized trials.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Staging; Prognosis; Remission Induction; Survival Rate | 2012 |
Chemotherapy, Irradiation, and Surgery for Function-preserving Curative Therapy of Primary Extremity Soft Tissue Sarcomas: Initial Treatment With I-MAP and Inhalation GM-CSF During Preoperative Irradiation and Postoperatively.
Topics: Administration, Inhalation; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Doxorubicin; Extremities; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Metastasis; Postoperative Period; Radiotherapy; Sarcoma; Soft Tissue Neoplasms; Young Adult | 2016 |
71 other study(ies) available for ifosfamide and mitomycin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
[Advances in the treatment of non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Vindesine | 1992 |
Analysis of the four combination chemotherapies in non-small cell lung cancer treated at Maharaj Nakorn Chiang Mai Hospital.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Mitomycin; Survival Rate; Vinblastine | 1992 |
Effects of chemotherapy on ultrastructure of oesophageal adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Nucleolus; Cisplatin; Combined Modality Therapy; Cytoplasmic Granules; Esophageal Neoplasms; Female; Humans; Ifosfamide; Lysosomes; Male; Middle Aged; Mitochondria; Mitomycin; Vacuoles | 1992 |
[Experimental chemotherapy of peritoneal carcinomatosis of colonic origin in rats].
Topics: Animals; Antineoplastic Agents; Cisplatin; Colonic Neoplasms; Cyclophosphamide; Disease Models, Animal; Drug Screening Assays, Antitumor; Female; Ifosfamide; Injections, Intraperitoneal; Injections, Intravenous; Male; Mitomycin; Peritoneal Neoplasms; Rats; Thiotepa | 1992 |
[The modification of the toxicity produced by chemotherapy in testicular cancer by adapting its intensity to prognostic groups].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Iatrogenic Disease; Ifosfamide; Male; Mitomycin; Prognosis; Testicular Neoplasms; Vinblastine; Vincristine | 1991 |
5-fluorouracil, ifosfamide and mitomycin (FIM) combination for pancreatic-biliary tumors.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Female; Fluorouracil; Humans; Ifosfamide; Male; Middle Aged; Mitomycin; Mitomycins; Pancreatic Neoplasms; Survival Rate | 1991 |
Mitomycin, ifosfamide and cisplatin in non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Evaluation; Female; Humans; Ifosfamide; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins | 1990 |
[Clinical efficacy of ifosfamide for liver metastasis of breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bicarbonates; Breast Neoplasms; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Ifosfamide; Liver Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Mitomycin; Mitomycins; Sodium; Sodium Bicarbonate | 1990 |
[Polychemotherapy of non-small cell bronchial cancer with mitomycin C, ifosfamide and vindesine].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Mitomycins; Vindesine | 1990 |
[Alternating combination chemotherapy (VIP-DMF) in patients with advanced adenocarcinoma of the prostate].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Drug Administration Schedule; Fluorouracil; Humans; Ifosfamide; Male; Middle Aged; Mitomycin; Mitomycins; Peplomycin; Prostatic Neoplasms; Vincristine | 1987 |
Mitomycin, ifosfamide and cis-platin in non-small cell lung cancer: treatment good enough to compare.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Evaluation; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins | 1988 |
[Chemotherapy with mitomycin C, vindesine and ifosfamide in the treatment of inoperable non-small cell bronchial carcinoma].
Topics: Adenocarcinoma; Aged; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Therapy, Combination; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Vindesine | 1985 |
Correlation of an in vitro chemosensitivity test using [3H] incorporation with the response in case of human tumor chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Carbazilquinone; Colony-Forming Units Assay; Cytarabine; Dactinomycin; Doxorubicin; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Ifosfamide; Male; Mechlorethamine; Middle Aged; Mitomycin; Mitomycins; Nimustine; Nitrogen Mustard Compounds; Nitrosourea Compounds; Tritium; Tumor Stem Cell Assay | 1986 |
[A case report of an advanced ovarian cancer (stage T4) treated with a total amount of 1815 mg of CDDP].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Mitomycin; Mitomycins; Ovarian Neoplasms | 1987 |
[Clinical evaluation on the sensitivity test for anti-cancer agents in malignant bone and soft-tissue tumors].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Resistance; Fluorouracil; Histiocytoma, Benign Fibrous; Humans; Ifosfamide; Lymphoma; Male; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Osteosarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms; Succinate Dehydrogenase; Vincristine | 1984 |
Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer.
Topics: Adult; Aged; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; CD57 Antigens; Cell Differentiation; Chromogranin A; Chromogranins; Cisplatin; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Humans; Ifosfamide; Immunologic Factors; Interferons; Karnofsky Performance Status; Life Tables; Lung Neoplasms; Male; Middle Aged; Mitomycin; Multivariate Analysis; Neoplasm Proteins; Neoplasm Staging; Phosphopyruvate Hydratase; Prognosis; Proportional Hazards Models; Remission Induction; Retrospective Studies; Survival Rate; Synaptophysin; Vindesine | 1993 |
Effects of chemotherapy on ultrastructure of oesophageal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Nucleus; Cisplatin; Cytoplasm; Cytoskeleton; Esophageal Neoplasms; Female; Humans; Ifosfamide; Male; Microscopy, Electron; Middle Aged; Mitomycin | 1994 |
Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Colonic Neoplasms; Cyclophosphamide; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Ifosfamide; Leukemia P388; Mammary Neoplasms, Animal; Melanoma, Experimental; Methotrexate; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Mitomycin; Sarcoma, Experimental; Vinblastine | 1994 |
Histopathological findings in oesophageal carcinoma with and without preoperative chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Doxorubicin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Ifosfamide; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Staging | 1993 |
Antitumor activity of treosulfan in human lung carcinomas.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Busulfan; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Male; Mice; Mice, Nude; Mitomycin; Neoplasm Transplantation; Time Factors | 1996 |
Lack of correlation of P-glycoprotein expression with response to MIC chemotherapy in oesophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Squamous Cell; Cisplatin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Esophageal Neoplasms; Female; Humans; Ifosfamide; Immunoenzyme Techniques; Male; Middle Aged; Mitomycin; Neoplasm Proteins | 1995 |
Histopathological grading of response to induction chemotherapy in non-small cell lung cancer: a preliminary study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Humans; Ifosfamide; Lung Neoplasms; Middle Aged; Mitomycin; Neoplasm Staging; Remission Induction; Vindesine | 1996 |
Lack of correlation of P-glycoprotein expression with response to MIC chemotherapy in oesophageal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Humans; Ifosfamide; Mitomycin | 1997 |
Response of dermatomyositis co-existing with non-small cell lung cancer to chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dermatomyositis; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Palliative Care | 1998 |
[Neoadjuvant chemotherapy for advanced cervical cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Humans; Hysterectomy; Ifosfamide; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Staging; Peplomycin; Pilot Projects; Prognosis; Uterine Cervical Neoplasms; Vinblastine; Vincristine | 1999 |
Evaluation of the TN sub-staging in patients with initially unresectable stage III non-small cell lung cancer treated by induction chemotherapy. The European Lung Cancer Working Party.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cohort Studies; Female; Humans; Ifosfamide; Karnofsky Performance Status; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Prognosis; Survival Analysis | 1998 |
Characterization of a human cell clone expressing cytochrome P450 for safe use in human somatic cell therapy.
Topics: Cell Division; Cell Line; Clone Cells; Cytochrome P-450 CYP2B1; Dose-Response Relationship, Drug; Gene Expression; Gene Transfer Techniques; Genetic Therapy; Humans; Ifosfamide; Mitomycin; Safety | 1999 |
[Surgical treatment of non-small cell lung cancer with mediastinal node invasion. A retrospective study].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Female; Humans; Ifosfamide; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Mediastinoscopy; Mediastinum; Middle Aged; Mitomycin; Neoplasm Staging; Pneumonectomy; Prognosis; Radiography; Radiotherapy, Adjuvant; Retrospective Studies; Spain; Survival Analysis; Thoracotomy; Treatment Outcome | 2001 |
[Surgery and combined therapy for non-small cell lung cancer with invasion of the mediastinal nodes. A retrospective study].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Humans; Ifosfamide; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Mitomycin; Neoplasm Staging; Retrospective Studies | 2001 |
[Concomitant radiochemotherapy for non-small-cell lung cancer: towards an ideal strategy].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Deoxycytidine; Gemcitabine; Humans; Ifosfamide; Immunologic Factors; Lung Neoplasms; Mitomycin; Neoplasm Metastasis; Paclitaxel; Radiation-Sensitizing Agents; Randomized Controlled Trials as Topic; Vinblastine; Vinorelbine | 2001 |
[Chemoradiotherapy-chemotherapy for grade III inoperable non-small-cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Female; Follow-Up Studies; France; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Multicenter Studies as Topic; Radiotherapy Dosage; Retrospective Studies; Survival Analysis; Time Factors | 2001 |
Managing poor performance non-small-cell lung cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Humans; Ifosfamide; Lung Neoplasms; Mitomycin | 2001 |
Neo-adjuvant chemotherapy in early stages of non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Neoplasm Recurrence, Local; Neoplasm Staging; Randomized Controlled Trials as Topic | 2002 |
A critical role for the cannabinoid CB1 receptors in alcohol dependence and stress-stimulated ethanol drinking.
Topics: Alcohol Drinking; Alcoholism; Animals; Antineoplastic Combined Chemotherapy Protocols; Ataxia; Behavior, Animal; Choice Behavior; Cisplatin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Tolerance; Electroshock; Ethanol; Hypothermia; Ifosfamide; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitomycin; Motor Activity; Receptor, Cannabinoid, CB1; Receptors, Cannabinoid; Receptors, Drug; Stress, Physiological; Substance Withdrawal Syndrome; Vindesine | 2003 |
Inhibition of induced chemoresistance by cotreatment with (E)-5-(2-bromovinyl)-2'-deoxyuridine (RP101).
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Cisplatin; DNA-Binding Proteins; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Electrophoresis, Gel, Two-Dimensional; Fibroblasts; Ifosfamide; Methotrexate; Mice; Mitomycin; Mitoxantrone; NAD(P)H Dehydrogenase (Quinone); Rats; Rats, Sprague-Dawley; Sarcoma, Yoshida; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; STAT3 Transcription Factor; Trans-Activators; Tumor Cells, Cultured; Vinblastine; Vinorelbine | 2003 |
Anti-HIV natural product (+)-calanolide A is active against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis.
Topics: Animals; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Antitubercular Agents; Cell Line; Chlorocebus aethiops; Cisplatin; Coumarins; DNA; Drug Resistance, Bacterial; Ifosfamide; Inhibitory Concentration 50; Macrophages; Microbial Sensitivity Tests; Mitomycin; Mycobacterium tuberculosis; Pyranocoumarins; Rifampin; RNA; Vero Cells; Virus Replication | 2004 |
Cytoreductive surgery plus intraperitoneal hyperthermic perfusion is an effective treatment for metastasized malignant mixed mesodermal tumours (MMMT)--report of six cases.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Chemotherapy, Cancer, Regional Perfusion; Combined Modality Therapy; Female; Germany; Humans; Hyperthermia, Induced; Ifosfamide; Laparotomy; Liver; Middle Aged; Mitomycin; Mixed Tumor, Malignant; Mixed Tumor, Mesodermal; Neoplasm Recurrence, Local; Neoplasm Staging; Peritoneal Cavity; Peritoneal Neoplasms; Treatment Outcome; Women's Health | 2004 |
Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Multivariate Analysis; Neoplasm Staging; Prognosis; Survival Analysis; Survival Rate | 2004 |
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant mixed mesodermal tumours with peritoneal dissemination.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Chemotherapy, Cancer, Regional Perfusion; Combined Modality Therapy; Female; Humans; Hyperthermia, Induced; Ifosfamide; Laparotomy; Liver; Mitomycin; Mixed Tumor, Malignant; Mixed Tumor, Mesodermal; Neoplasm Recurrence, Local; Neoplasm Staging; Peritoneal Cavity; Peritoneal Neoplasms; Treatment Outcome; Women's Health | 2005 |
Gene expression in primary cultured mouse hepatocytes with a cationic liposomal vector, TFL-3: comparison with rat hepatocytes.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cells, Cultured; Cisplatin; Gene Expression; Hepatocytes; Ifosfamide; Liposomes; Mitomycin; Rats | 2005 |
Is the tolerance to MIP chemotherapy different between English and other European populations?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Clinical Trials, Phase III as Topic; Decision Making; Deoxycytidine; England; Europe; Gemcitabine; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Randomized Controlled Trials as Topic; Reproducibility of Results | 2005 |
Complete response following preoperative chemotherapy for resectable non-small cell lung cancer: accuracy of clinical assessment using the French trial database.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Databases as Topic; France; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Neoadjuvant Therapy; Neoplasm Staging; Pneumonectomy; Predictive Value of Tests; Prospective Studies; Remission Induction; Tomography, X-Ray Computed; Treatment Outcome | 2005 |
Is the paraneoplastic syndrome of inappropriate antidiuretic hormone secretion in lung cancer always attributable to the small cell variety?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Humans; Ifosfamide; Inappropriate ADH Syndrome; Lung Neoplasms; Male; Middle Aged; Mitomycin; Paraneoplastic Syndromes; Radiography | 2005 |
[Current data concerning neoadjuvant chemotherapy].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Ifosfamide; Lung; Lung Neoplasms; Mitomycin; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Radiotherapy Dosage; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Risk; Time Factors | 2006 |
The putative endocannabinoid transport blocker LY2183240 is a potent inhibitor of FAAH and several other brain serine hydrolases.
Topics: Amidohydrolases; Animals; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Brain; Cannabinoid Receptor Modulators; Carbamates; Cisplatin; Endocannabinoids; Gene Deletion; Heterocyclic Compounds, 1-Ring; Hydrolases; Ifosfamide; Male; Mice; Mice, Inbred C57BL; Mitomycin; Molecular Structure; Urea | 2006 |
[Comparing cisplatin plus etoposide with combination of mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer patients].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Metastasis; Retrospective Studies; Survival Analysis; Treatment Outcome; Turkey | 2006 |
CD4+ T cells from Copolymer-1 immunized mice protect dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adoptive Transfer; Animals; Antineoplastic Combined Chemotherapy Protocols; CD4-Positive T-Lymphocytes; Cisplatin; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Glatiramer Acetate; Ifosfamide; Male; Mice; Mitomycin; Neurons; Parkinson Disease, Secondary; Peptides; Substantia Nigra; Tyrosine 3-Monooxygenase | 2007 |
6,11-Dideoxytetrodotoxin from the puffer fish, Fugu pardalis.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Ifosfamide; Mitomycin; Molecular Structure; Ovary; Takifugu; Tetrodotoxin | 2007 |
Combining a solution-phase derived library with in-situ cellular bioassay: prompt screening of amide-forming minilibraries using MTT assay.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cisplatin; Combinatorial Chemistry Techniques; Ifosfamide; Mitomycin; Models, Molecular; Molecular Structure; Small Molecule Libraries | 2009 |
Primary squamous cell carcinoma of the breast: achieving long-term control with cisplatin-based chemotherapy.
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Ifosfamide; Mastectomy; Mitomycin | 2009 |
From mouse to moose: multilocus genotyping of Giardia isolates from various animal species.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cats; Cisplatin; Cytoskeletal Proteins; Dogs; Feces; Genes, rRNA; Genotype; Giardia; Giardiasis; Host-Parasite Interactions; Ifosfamide; Mitomycin; Molecular Sequence Data; Parasitic Diseases, Animal; Phylogeny; Protozoan Proteins; Sugar Alcohol Dehydrogenases; Sweden; Triose-Phosphate Isomerase | 2010 |
Genomic integration of adenoviral gene transfer vectors following transduction of fertilized mouse oocytes.
Topics: Adenoviruses, Human; Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Embryo, Mammalian; Female; Gene Transfer Techniques; Genetic Vectors; Green Fluorescent Proteins; Humans; Ifosfamide; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Transgenic; Mitomycin; Oocytes; Recombination, Genetic; Transduction, Genetic; Transgenes; Virus Integration | 2011 |
Antibodies interfering with the type 3 muscarinic receptor pathway inhibit gastrointestinal motility and cholinergic neurotransmission in Sjögren's syndrome.
Topics: Acetylcholine; Analysis of Variance; Animals; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Carbachol; Cholinergic Agonists; Cisplatin; Gastrointestinal Motility; Humans; Ifosfamide; Male; Mice; Mice, Knockout; Mitomycin; Muscle Contraction; Muscle, Smooth; Receptor, Muscarinic M3; Sjogren's Syndrome; Synaptic Transmission | 2011 |
Inflammation: cell recruitment versus local proliferation.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blood; Cell Proliferation; Cisplatin; Filariasis; Filarioidea; Ifosfamide; Inflammation; Interleukin-4; Macrophage Activation; Macrophages; Mitomycin; Monocytes; Th2 Cells | 2011 |
Loss of sorting nexin 27 contributes to excitatory synaptic dysfunction by modulating glutamate receptor recycling in Down's syndrome.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; C-Reactive Protein; CCAAT-Enhancer-Binding Protein-beta; CCAAT-Enhancer-Binding Proteins; Cerebral Cortex; Cisplatin; Down Syndrome; Down-Regulation; Female; Hippocampus; Humans; Ifosfamide; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; Mitomycin; Nerve Tissue Proteins; Receptors, Glutamate; Sorting Nexins; Synapses; Transcription Factors | 2013 |
ERCC1 expression does not predict survival and treatment response in advanced stage non-small cell lung cancer cases treated with platinum based chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; DNA-Binding Proteins; Docetaxel; Endonucleases; Female; Follow-Up Studies; Glutamates; Guanine; Humans; Ifosfamide; Immunoenzyme Techniques; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Pemetrexed; Prognosis; Retrospective Studies; Survival Rate; Taxoids | 2013 |
Extraskeletal Osteosarcoma: An International Rare Cancer Network Study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Deoxycytidine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; Ifosfamide; Lower Extremity; Male; Methotrexate; Middle Aged; Mitomycin; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Osteosarcoma; Pelvic Neoplasms; Prognosis; Radiotherapy; Rare Diseases; Retroperitoneal Neoplasms; Retrospective Studies; Soft Tissue Neoplasms; Tumor Burden; Young Adult | 2016 |
Recurrent metastatic anal cancer treated with modified paclitaxel, ifosfamide, and cisplatin and third-line mitomycin/cetuximab.
Topics: Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Humans; Ifosfamide; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Paclitaxel | 2015 |
Novel influenza A(H7N2) virus in chickens, Jilin province, China, 2014.
Topics: Animals; Antibodies, Viral; Antineoplastic Combined Chemotherapy Protocols; Biological Assay; Chickens; China; Cisplatin; Female; Humans; Ifosfamide; Influenza A Virus, H7N2 Subtype; Influenza A Virus, H7N9 Subtype; Influenza in Birds; Male; Mice, Inbred BALB C; Middle Aged; Mitomycin; Orthomyxoviridae Infections; Virus Replication | 2014 |
Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma.
Topics: Adenocarcinoma; Aged; Albumin-Bound Paclitaxel; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Gemcitabine; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Middle Aged; Mitomycin; Neoadjuvant Therapy; Paclitaxel; Perioperative Care; Retrospective Studies; Urethra; Urethral Neoplasms; Urinary Diversion | 2015 |
Sirtuin 3 regulates Foxo3a-mediated antioxidant pathway in microglia.
Topics: Active Transport, Cell Nucleus; Animals; Animals, Newborn; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Brain Injuries; Catalase; Cell Line; Cisplatin; Corpus Callosum; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Knockdown Techniques; Ifosfamide; Lipopolysaccharides; Mice, Knockout; Microglia; Mitomycin; Rats, Wistar; Reactive Oxygen Species; Sirtuin 3; Sirtuins; Superoxide Dismutase | 2015 |
Dewaxed Brown Rice Contains a Significant Amount of Lipopolysaccharide Pointing to Macrophage Activation via TLRs.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Ifosfamide; Immunity, Innate; Lipopolysaccharides; Macrophage Activation; Mice; Mitomycin; Nitric Oxide; Oryza; RAW 264.7 Cells; Toll-Like Receptor 4; Waxes | 2016 |
Lower Abundance and Impaired Function of CD71+ Erythroid Cells in Inflammatory Bowel Disease Patients During Pregnancy.
Topics: Animals; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Models, Animal; Erythroid Cells; Female; Humans; Ifosfamide; Inflammatory Bowel Diseases; Mice, Inbred BALB C; Mice, Inbred C57BL; Mitomycin; Pregnancy; Pregnancy Complications; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Transferrin; Transcriptome | 2019 |
Chronic mild stress induced anxiety-like behaviors can Be attenuated by inhibition of NOX2-derived oxidative stress.
Topics: Acetophenones; Animals; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Cisplatin; Hippocampus; Ifosfamide; Male; Mice; Mice, Inbred C57BL; Mitomycin; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Stress, Psychological | 2019 |
Mannosylated chitosan nanoparticles loaded with FliC antigen as a novel vaccine candidate against Brucella melitensis and Brucella abortus infection.
Topics: Animals; Antigens, Bacterial; Antineoplastic Combined Chemotherapy Protocols; Brucella abortus; Brucella melitensis; Brucella Vaccine; Brucellosis; Chitosan; Cisplatin; Female; Ifosfamide; Mannose; Mice, Inbred BALB C; Mitomycin; Nanoparticles | 2020 |
Chronic Toxoplasma gondii Infection Alleviates Experimental Autoimmune Encephalomyelitis by the Immune Regulation Inducing Reduction in IL-17A/Th17 Via Upregulation of SOCS3.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Brain; Cisplatin; Encephalomyelitis, Autoimmune, Experimental; Flow Cytometry; Fluorescent Antibody Technique; Ifosfamide; Interleukin-17; Mice, Inbred C57BL; Mitomycin; Suppressor of Cytokine Signaling 3 Protein; Th17 Cells; Toxoplasmosis | 2021 |
MTSS1 inhibits colorectal cancer metastasis by regulating the CXCR4/CXCL12 signaling axis.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Chemokine CXCL12; Cisplatin; Colorectal Neoplasms; HT29 Cells; Humans; Ifosfamide; Male; Mice, Inbred BALB C; Mice, Nude; Microfilament Proteins; Mitomycin; Neoplasm Metastasis; Neoplasm Proteins; Receptors, CXCR4; Signal Transduction | 2021 |
Development of Potent NEDD8-Activating Enzyme Inhibitors Bearing a Pyrimidotriazole Scaffold.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cisplatin; Drug Design; Enzyme Inhibitors; Humans; Ifosfamide; Mitomycin; Tirapazamine; Tissue Distribution; Ubiquitin-Activating Enzymes; Xenograft Model Antitumor Assays | 2021 |